Congenital CMV Causes >10 Percent of Hearing-Loss Cases

This article originally appeared here.
Share this content:
Congenital CMV Causes >10 Percent of Hearing-Loss Cases
Congenital CMV Causes >10 Percent of Hearing-Loss Cases

(HealthDay News) -- More than 10 percent of infants with congenital cytomegalovirus (cCMV) will suffer permanent hearing loss, according to new research published online Oct. 27 in Pediatrics.

To identify how widespread cCMV is in children, and to determine its toll on hearing, Julie Goderis, M.D., of University Hospital Ghent in Belgium, and colleagues culled data from 37 previously published studies. The researchers found that the virus strikes less than 1 percent of newborns -- about 0.58 percent -- in developed countries. And about 12.6 percent of infected children will suffer severe, permanent hearing loss. Among children who show virus symptoms, one in three children suffers hearing loss, compared to one of 10 who doesn't have symptoms.

For symptomatic children, hearing loss will affect both ears. Children without symptoms usually suffer hearing loss in one ear, Goderis told HealthDay. Hearing loss from cCMV, which is severe to total, can develop over time and vary as it progresses, she explained. But only one in 10 children with the virus shows symptoms, and screening is not routine, Goderis added.

"Until a vaccine becomes available, behavioral and educational interventions are the most effective strategy to prevent mothers from being infected with cCMV," she said. "Following up a child's hearing until the age of 6 years is essential to detect delayed onset or progressive hearing loss from cCMV," said Goderis. "We know that, especially in this group, delayed hearing loss can occur."

Full Article
Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »